Atea Pharmaceuticals' board of directors comprises seasoned biotechnology executives, financial experts, and independent industry leaders—including Jean-Pierre Sommadossi (Founder, Chairman, and CEO), along with independent directors possessing deep operational backgrounds in pharmaceutical research, clinical development, and corporate governance.